Skip to main content

Table 1 Reasons for OnabotulinumtoxinA discontinuation prior to 24 months

From: A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience

Discontinuations due to:

n = 29 (16.9 %)

OnabotulinumtoxinA indepent AEs

7 (4.1 %)

Not effective

5 (2.9 %)

Pregnancy

4 (2.3 %)

Drop out

6 (3.5 %)

Personal reasons

7 (4.1 %)

  1. AEs adverse events
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us